Fecal Calprotectin Test for IBS & IBD at Dr. Essa Lab

Fecal Calprotectin at Dr. Essa Lab

Fecal Calprotectin is a highly sensitive, non-invasive diagnostic biomarker utilized primarily to detect and monitor inflammatory processes within the gastrointestinal tract. Calprotectin is a 36.5 kDa calcium- and zinc-binding protein complex, structurally composed of S100A8 and S100A9 light chains, which is found abundantly in the cytosol of neutrophilic granulocytes, representing up to 60% of their total cytosolic protein content. When inflammatory pathology compromises the integrity of the intestinal mucosa, neutrophils migrate through the endothelial and epithelial barriers into the intestinal lumen. Consequently, calprotectin is shed directly into the feces. This protein complex is remarkably stable in stool specimens, resisting enzymatic degradation by colonic bacteria and remaining viable at room temperature for up to seven days, which makes it an exceptional laboratory analyte for clinical assessment.

At Dr. Essa Lab (Dr. Essa Laboratory & Diagnostic Centre), a premier diagnostic institution headquartered in Karachi, Pakistan, the Fecal Calprotectin test is performed using advanced quantitative immunoassay methodologies, such as Enzyme-Linked Immunosorbent Assay (ELISA) or chemiluminescence. This diagnostic tool provides critical clinical value by allowing gastroenterologists to differentiate between organic inflammatory bowel diseases (IBD), such as Crohn's disease and Ulcerative Colitis, and functional gastrointestinal disorders, such as Irritable Bowel Syndrome (IBS), which do not involve mucosal inflammation. By utilizing this highly specific biomarker, healthcare providers can avoid unnecessary, invasive, and costly endoscopic procedures for patients with functional symptoms, while rapidly identifying those who require urgent colonoscopy and histopathological evaluation.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the utmost clinical accuracy of the Fecal Calprotectin test and prevent false-positive or false-negative results, patients must adhere to the following preparation guidelines:

• Medication Adjustment: Patients should consult their referring physician regarding the temporary cessation of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as ibuprofen, naproxen, or high-dose aspirin, for at least two weeks prior to sample collection. NSAIDs can induce subclinical mucosal inflammation in the small and large intestines, leading to artificially elevated calprotectin levels.
• Proton Pump Inhibitors (PPIs): Long-term use of PPIs may alter the gut microbiome and cause mild intestinal inflammation. Discuss with your physician if these medications need to be paused.
• Avoid During Active Bleeding: Stool collection should not be performed during periods of active hemorrhoidal bleeding, severe menstrual bleeding, or significant upper gastrointestinal bleeding, as the presence of blood-derived neutrophils in the stool can cause false elevations.
• Dietary Restrictions: There are no specific dietary or fasting requirements for this test; patients may eat and drink normally prior to sample collection.
• Collection Container: Use only the sterile, preservative-free stool collection container provided by Dr. Essa Lab. Do not use any home containers or containers containing chemical preservatives.

During the Procedure

The collection of the stool specimen is a simple, non-invasive process that is completed by the patient at home or at a Dr. Essa Lab facility:

• Sample Collection: The patient must collect a fresh stool sample, ensuring it does not come into contact with toilet water, urine, or household cleaning agents, as these contaminants can degrade the calprotectin protein.
• Specimen Volume: Approximately 1 to 2 grams of solid or semi-solid stool (roughly the size of a walnut) should be transferred into the sterile container using the spatula attached to the container cap. For liquid stools, a similar volume should be carefully spooned.
• Storage and Transport: The specimen must be tightly sealed, labeled with the patient's full name, registration number, and collection time, and transported to the nearest Dr. Essa Lab collection point as soon as possible. If a delay of more than two hours is expected, the sample should be refrigerated at 2 to 8 degrees Celsius (do not freeze).
• Laboratory Processing: Upon arrival at the Dr. Essa Lab pathology department, the sample undergoes standardized extraction. The extract is then analyzed using state-of-the-art automated ELISA systems to measure the exact concentration of calprotectin in micrograms per gram (µg/g) of stool.

When is a Fecal Calprotectin Test Performed?

Differentiating Inflammatory Bowel Disease (IBD) from Irritable Bowel Syndrome (IBS)

Gastroenterologists frequently request a Fecal Calprotectin test when a patient presents with overlapping symptoms of chronic abdominal pain, bloating, and altered bowel habits. Because IBS (a functional disorder) and IBD (an organic inflammatory disease) share highly similar clinical presentations, this test serves as an essential, non-invasive triage tool. A normal calprotectin level strongly points toward a functional origin like IBS, sparing the patient from invasive diagnostic procedures.

Monitoring Disease Activity in Crohn's Disease and Ulcerative Colitis

For patients with established diagnoses of Inflammatory Bowel Disease, serial Fecal Calprotectin measurements are invaluable for monitoring disease activity. The test helps clinicians objectively assess whether a patient is in clinical remission or experiencing a subclinical flare-up. Elevated levels often precede clinical symptoms of a relapse by several weeks, allowing for proactive therapeutic adjustments.

Evaluating Unexplained Chronic Diarrhea and Abdominal Pain

When patients present with persistent, unexplained diarrhea and abdominal pain lasting more than four weeks, clinical guidelines recommend checking Fecal Calprotectin. This helps rule out underlying organic pathologies such as microscopic colitis, infectious enterocolitis, or drug-induced enteropathy, guiding the subsequent diagnostic pathway toward targeted interventions.

Assessing Pediatric Gastrointestinal Symptoms

In pediatric medicine, avoiding invasive procedures like colonoscopies under general anesthesia is highly desirable. Pediatricians utilize Fecal Calprotectin to screen children presenting with recurrent abdominal pain, growth failure, unexplained fever, or chronic diarrhea. This ensures that only children with high objective markers of mucosal inflammation undergo invasive endoscopic evaluations.

Detecting Gastrointestinal Inflammation and Therapy Response

Following the initiation of therapeutic regimens such as biologics, immunomodulators, or corticosteroids in IBD patients, Fecal Calprotectin is used to assess mucosal healing. A significant decline in calprotectin levels toward the normal range indicates a positive response to therapy, serving as an objective surrogate marker for endoscopic mucosal healing.

What Does a Fecal Calprotectin Test Detect?

The quantitative measurement of Fecal Calprotectin can detect and help evaluate a wide spectrum of clinical conditions and physiological states, including:

• Active mucosal inflammation associated with Ulcerative Colitis.
• Active transmural inflammation associated with Crohn's disease.
• The absence of active intestinal inflammation, pointing toward functional Irritable Bowel Syndrome (IBS).
• Infectious gastroenteritis caused by bacterial pathogens such as Salmonella, Shigella, Campylobacter, or Clostridioides difficile.
• NSAID-induced enteropathy and localized small bowel ulcerations.
• Acute diverticulitis with localized colonic inflammation.
• Colorectal neoplasia, including advanced adenomas and colorectal carcinoma, which often present with localized inflammatory responses.
• Active Celiac Disease characterized by significant mucosal inflammation prior to dietary modification.
• Microscopic colitis, including collagenous and lymphocytic subtypes.
• Gastrointestinal graft-versus-host disease (GvHD) in post-hematopoietic stem cell transplant patients.
• Food protein-induced enterocolitis syndrome (FPIES) in pediatric populations.
• Intestinal tuberculosis, a crucial differential diagnosis in Pakistan presenting with chronic bowel inflammation.
• Subclinical mucosal inflammation indicating an impending clinical relapse in IBD patients.
• Successful mucosal healing following targeted biological or immunosuppressive therapy.
• Juvenile polyps in pediatric patients presenting with rectal bleeding and localized inflammation.
• Ischemic colitis resulting from compromised mesenteric blood flow.
• Radiation-induced enteritis or proctitis in patients undergoing pelvic radiotherapy.
• Autoimmune enteropathy presenting with severe, refractory diarrhea.
• Eosinophilic gastroenteritis characterized by mucosal eosinophilic infiltration.
• Necrotizing enterocolitis (NEC) in neonatal and pediatric intensive care settings.

Turnaround Time and Report Access at Dr. Essa Lab

Dr. Essa Lab is widely recognized across Pakistan for its commitment to diagnostic excellence, rapid turnaround times, and seamless patient services. The turnaround time for a Fecal Calprotectin test is typically 24 to 48 hours from the time the specimen is received at the main testing laboratory. Because calprotectin is a specialized immunoassay, it is processed under strict quality control protocols supervised by consultant pathologists.

Patients can conveniently access their diagnostic reports online through the official Dr. Essa Lab web portal or dedicated mobile application. By entering the unique Lab ID and password provided on the receipt, patients and their referring physicians can view, download, and print high-resolution, verified PDF reports. Additionally, physical copies of the reports can be collected from any of the numerous Dr. Essa Lab collection centers situated throughout Karachi and other major cities.

Fecal Calprotectin Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Calprotectin Concentration	< 50 µg/g (Indicates no significant intestinal inflammation)	> 50 to 120 µg/g (Borderline/Mild); > 120 µg/g (Significant active inflammation)
Intestinal Mucosal Integrity	Intact, healthy mucosal barrier with normal neutrophil turnover	Compromised mucosal barrier with active neutrophilic infiltration and shedding
IBD vs. IBS Differentiation	Highly suggestive of functional IBS (if symptoms are present)	Highly suggestive of active organic pathology like Crohn's or Ulcerative Colitis
Therapeutic Response	Stable low levels indicating sustained mucosal healing	Persistently high or rising levels indicating therapy failure or impending relapse
Pediatric Baseline (>4 years)	< 50 µg/g (Adult equivalent reference range)	Elevated levels indicating pediatric IBD, food allergies, or infections
Drug-Induced Changes	No mucosal irritation (absence of NSAID/PPI impact)	Mild to moderate elevation (50-150 µg/g) due to drug-induced enteropathy
Infectious Colitis Status	No active bacterial or parasitic mucosal invasion	Markedly elevated levels during acute bacterial enterocolitis

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient's symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Fecal Calprotectin?

• Pathology Leadership: Established in 1987 by Prof. Dr. Essa M. Abdulla, Dr. Essa Lab is one of Pakistan's most trusted diagnostic institutions.
• Highly Qualified Specialists: All tests are performed under the direct supervision of board-certified consultant pathologists and clinical microbiologists.
• Advanced ELISA Technology: Utilization of state-of-the-art automated immunoassay platforms ensures highly precise and reproducible quantitative results.
• ISO Certified Standards: Operating under stringent international quality control guidelines and ISO certifications to maintain diagnostic accuracy.
• Extensive Collection Network: Convenient sample drop-off points located across Karachi and other major cities in Pakistan.
• Secure Online Reports: Rapid and secure access to digital reports via the official website and mobile app.
• Affordable Diagnostics: Offering high-quality, specialized gastroenterology testing at competitive and accessible pricing.
• Patient-Centric Care: Dedicated support staff and comfortable, hygienic environments at all diagnostic centers to ensure a seamless patient experience.